Wachtel H - Search Results

1

In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.

Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, Finlay WH. Byron PR, et al. Among authors: wachtel h. J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S59-69. doi: 10.1089/jamp.2010.0846. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 21133801 Review.

2

In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.

Dellweg D, Wachtel H, Höhn E, Pieper MP, Barchfeld T, Köhler D, Glaab T. Dellweg D, et al. Among authors: wachtel h. J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):285-92. doi: 10.1089/jamp.2011.0883. Epub 2011 Aug 26. J Aerosol Med Pulm Drug Deliv. 2011. PMID: 21870959

3

Regional deposition of nasal sprays in adults: A wide ranging computational study.

Kiaee M, Wachtel H, Noga ML, Martin AR, Finlay WH. Kiaee M, et al. Among authors: wachtel h. Int J Numer Method Biomed Eng. 2018 May;34(5):e2968. doi: 10.1002/cnm.2968. Epub 2018 Mar 25. Int J Numer Method Biomed Eng. 2018. PMID: 29453801

4

An idealized geometry that mimics average nasal spray deposition in adults: A computational study.

Kiaee M, Wachtel H, Noga ML, Martin AR, Finlay WH. Kiaee M, et al. Among authors: wachtel h. Comput Biol Med. 2019 Apr;107:206-217. doi: 10.1016/j.compbiomed.2019.02.013. Epub 2019 Feb 26. Comput Biol Med. 2019. PMID: 30851506

5

Use of Airway Replicas in Lung Delivery Applications.

Golshahi L, Finlay WH, Wachtel H. Golshahi L, et al. Among authors: wachtel h. J Aerosol Med Pulm Drug Deliv. 2022 Apr;35(2):61-72. doi: 10.1089/jamp.2021.29057.lg. Epub 2022 Mar 8. J Aerosol Med Pulm Drug Deliv. 2022. PMID: 35262408 Review.

6

A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old.

Kamin W, Frank M, Kattenbeck S, Moroni-Zentgraf P, Wachtel H, Zielen S. Kamin W, et al. Among authors: wachtel h. J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):372-81. doi: 10.1089/jamp.2014.1159. Epub 2015 Apr 6. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25844687 Free PMC article.

7

Lung Deposition Using the Respimat^® Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/In Silico Analysis.

Ciciliani AM, Denny M, Langguth P, Voshaar T, Wachtel H. Ciciliani AM, et al. Among authors: wachtel h. COPD. 2021 Feb;18(1):91-100. doi: 10.1080/15412555.2020.1853091. Epub 2020 Dec 11. COPD. 2021. PMID: 33302718 Free article.

8

In Vitro Determination of Respimat^® Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth-Throat Models.

Bickmann D, Kamin W, Sharma A, Wachtel H, Moroni-Zentgraf P, Zielen S. Bickmann D, et al. Among authors: wachtel h. J Aerosol Med Pulm Drug Deliv. 2016 Feb;29(1):76-85. doi: 10.1089/jamp.2014.1166. Epub 2015 Jun 22. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26098994 Free PMC article.

9

In vitro dose comparison of Respimat^® inhaler with dry powder inhalers for COPD maintenance therapy.

Ciciliani AM, Langguth P, Wachtel H. Ciciliani AM, et al. Among authors: wachtel h. Int J Chron Obstruct Pulmon Dis. 2017 May 26;12:1565-1577. doi: 10.2147/COPD.S115886. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28603412 Free PMC article.

10

Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.

Hochrainer D, Hölz H, Kreher C, Scaffidi L, Spallek M, Wachtel H. Hochrainer D, et al. Among authors: wachtel h. J Aerosol Med. 2005 Fall;18(3):273-82. doi: 10.1089/jam.2005.18.273. J Aerosol Med. 2005. PMID: 16181002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters